2.45 - 3.30
ArchiMate® as a Communication Tool in Launching an EA Effort
This presentation will focus on:
- Harmonizing and Promulgating a Vision for Supporting the Business Strategy
- How to use Archimate in structuring communications
- ArchiMate vs. UML for representing your Enterprise Architecture: what content fits where for which audience
Andy Siegel, Director of Enterprise Architecture, Genzyme
Andy Siegel is the Director of Enterprise Architecture at Genzyme Corporation and has over 25 years of experience in biomedical informatics and data science. He is currently working in the area of clinical data standards and systems architecture and has worked in clinical R&D IT groups with large and small biopharmaceutical companies since 1984. Prior to his tenure at Genzyme, Andy was the Assistant Director, Medical and Regulatory Information Technology at Astra Pharmaceuticals. At Astra, Andy was responsible for Astra’s first eIND and eNDA in addition to multiple other electronic regulatory filings. Before joining Astra in 1993, Andy held clinical project management and SAS systems analyst positions with Adria Laboratories and Pfizer Central Research.
Andy is now responsible for planning, architecting and managing the introduction of core infrastructure technologies to support an emerging standards based end-to-end metadata driven eClinical business process for Genzyme’s Biomedical Informatics and Data Sciences group. Andy has an MS in Biomedical Mathematics and Engineering from the University of North Carolina at Chapel Hill. Andy, his wife Mary and 2 daughters live in Sudbury, Massachusetts.
Richard Ferrante, Principal RDF Software Group, EA architecture consultant to Genzyme BMRA
Richard has over 20 years experience in the design and development of systems in the scientific and engineering domains. He has served as both and enterprise and applications architect for a major biopharmaceutical company and has developed a number of algorithms and systems for scientific/engineering use.
Prior Talks:
- Ferrante, R. D, Applications, Standards, and Architecture in Practice BioIT World, May 2007
- Ferrante, R. D, CDISC Life Sciences Industry Architecture: Goals and Current Status Clinical Trials Congress, February 2007
- Ferrante, R. D. And Kuo, A.D., Building a Clinical Data Warehouse Bridging Pharma and IT, September
- 2006 Hubs and Connectors: A Mechanism for Integrating Multiple Sources of Chemical Data, I3C Annual Meeting, May 2003
Hemant Virkar, CEO, Digital Infuzion
Mr. Hemant Virkar is the President, CEO, and founder of Digital Infuzion, Inc., and has over 23 years of experience in strategic planning, architecting and implementing large-scale enterprise systems in the biomedical domain. He holds Master of Science degrees in Computer Science and Computer Engineering, and a Bachelor of Science degree in Physics.
Mr. Virkar served as the Chief Software Architect for the National Institute of Health's Division of AIDS Clinical Research Management System and was responsible for crafting the architectural vision and technology strategy for the system which supports this approximately $1 billion/year clinical research program. Mr. Virkar also served as the Principal Investigator for the National Cancer Institute’s Cancer Therapy and Evaluation Program Enterprise System project, supporting over 10,000 protocols, 15,000 investigators, 8,000 sites and 3,000 drug agents.
Mr. Virkar is an expert in the full software lifecycle of large-scale IT projects, serves as a member of the CDISC Industry Advisory Board (IAB), and actively participates in HL7 working groups. He has a keen interest in adapting innovative information technologies from a variety of industries (e.g. banking, travel, and entertainment) for use in the healthcare space to improve how we communicate and use information to advance clinical research and clinical care.
|